Ad
BDSI - BioDelivery Sciences International Stock Trading
About | BioDelivery Sciences International Inc. (NASDAQ:BDSI)
Not available
Quote | BioDelivery Sciences International Inc. (NASDAQ:BDSI)
| Last: | $5.59 |
|---|---|
| Change Percent: | -0.09% |
| Open: | $5.6 |
| Close: | $5.59 |
| High: | $5.6 |
| Low: | $5.59 |
| Volume: | 2,090,567 |
| Last Trade Date Time: | 03/22/2022 04:54:15 pm |
News | BioDelivery Sciences International Inc. (NASDAQ:BDSI)
-
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
-
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Message Board Posts | BioDelivery Sciences International Inc. (NASDAQ:BDSI)
| Subject | By | Source | When |
|---|---|---|---|
| Guess nobody noticed that $BDSI is being bought | north40000 | investorshub | 02/14/2022 6:52:45 PM |
| whytestocks: $BDSI News Article - BIODELIVERY SCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigat | whytestocks | investorshangout | 02/14/2022 5:25:48 PM |
| whytestocks: $BDSI News Article - Merger Mania Is Sending These 2 Little-Known Stocks Soaring | whytestocks | investorshangout | 02/14/2022 4:45:49 PM |
| whytestocks: $BDSI News Article - BDSI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sa | whytestocks | investorshangout | 02/14/2022 4:35:49 PM |
| whytestocks: $BDSI News Article - Collegium to Acquire BioDelivery Sciences in an All-Cash Deal | whytestocks | investorshangout | 02/14/2022 2:50:48 PM |
BioDelivery Sciences International Inc. Company Name:
BDSI Stock Symbol:
NASDAQ Market:
Ad
-
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
-
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
-
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...